Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

dapagliflozin MeSH Supplementary Concept Data 2025


MeSH Supplementary
dapagliflozin
Unique ID
C529054
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C529054
Entry Term(s)
(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6- (hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol
2-(3-(4-ethoxybenzyl)-4-chlorophenyl)-6-hydroxymethyltetrahydro-2H-pyran-3,4,5-triol
BMS 512148
BMS-512148
BMS512148
Farxiga
Forxiga
Pharm Action
Sodium-Glucose Transporter 2 Inhibitors
Registry Numbers
1ULL0QJ8UC
0
Heading Mapped to
*Benzhydryl Compounds
*Glucosides
Frequency
1280
Source
Drug News Perspect 2007 Dec;20(10):645
Date of Entry
2008/05/21
Revision Date
2021/05/03
dapagliflozin Preferred
2-(3-(4-ethoxybenzyl)-4-chlorophenyl)-6-hydroxymethyltetrahydro-2H-pyran-3,4,5-triol Broader
BMS 512148 Narrower
Farxiga Narrower
page delivered in 0.004s